Venus Concept ( (VERO) ) has shared an announcement.
On March 31, 2025, Venus Concept Inc. completed an $11 million debt-to-equity exchange with Madryn Health Partners, reducing its debt obligations significantly. This transaction, which involved the conversion of subordinated convertible notes into Series Y preferred stock, is part of the company’s strategy to optimize its capital structure and enhance financial flexibility, supporting its long-term growth and profitability goals.
More about Venus Concept
Venus Concept is a global leader in medical aesthetic technology, offering a diverse range of minimally invasive and non-invasive aesthetic and hair restoration technologies. The company’s product portfolio includes platforms such as Venus Versa, Venus Legacy, and ARTAS iX Robotic Hair Restoration system, reaching over 60 countries and 10 direct markets.
YTD Price Performance: -36.71%
Average Trading Volume: 66,394
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.84M
For detailed information about VERO stock, go to TipRanks’ Stock Analysis page.